Scientific article
Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer
Published inThe cancer journal, vol. 12, no. 1, p. 63-68
Publication date2006
Abstract
Keywords
- Aged
- Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse effects
- Carcinoma, Squamous Cell/pathology/therapy
- Cisplatin/administration & dosage/adverse effects
- Combined Modality Therapy
- Deglutition Disorders/etiology
- Dose Fractionation
- Dose-Response Relationship, Drug
- Female
- Head and Neck Neoplasms/pathology/therapy
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Mucositis/etiology
- Neck Dissection
- Neoplasm Staging
- Taxoids/administration & dosage/adverse effects
- Treatment Outcome
Citation (ISO format)
ALLAL, Abdelkarim Said et al. Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer. In: The cancer journal, 2006, vol. 12, n° 1, p. 63–68. doi: 10.1097/00130404-200601000-00011
Main files (1)
Article (Published version)
Identifiers
- PID : unige:33098
- DOI : 10.1097/00130404-200601000-00011
- PMID : 16613664
Journal ISSN1528-9117
